These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17216825

  • 1. Hypoglycemia in the setting of advanced gastrointestinal stromal tumor.
    Guiteau J, Fanucchi M, Folpe A, Staley CA, Kooby DA.
    Am Surg; 2006 Dec; 72(12):1225-30. PubMed ID: 17216825
    [Abstract] [Full Text] [Related]

  • 2. A case of insulin-like growth factor 2-producing gastrointestinal stromal tumor with severe hypoglycemia.
    Yamasaki H, Itawaki A, Morita M, Miyake H, Yamamoto M, Sonoyama H, Tanaka S, Notsu M, Yamauchi M, Fujii Y, Ishikawa N, Fukuda I, Ishihara S, Kanasaki K.
    BMC Endocr Disord; 2020 May 11; 20(1):60. PubMed ID: 32393233
    [Abstract] [Full Text] [Related]

  • 3. Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate.
    Hamada M, Ozaki K, Horimi T, Tsuji A, Nasu Y, Iwata J, Nagata Y.
    Int J Clin Oncol; 2008 Aug 11; 13(4):355-60. PubMed ID: 18704638
    [Abstract] [Full Text] [Related]

  • 4. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF, Perry CM.
    Drugs; 2003 Aug 11; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [Abstract] [Full Text] [Related]

  • 5. Complete remission of recurrent gastrointestinal stromal tumors after treatment with imatinib: report of a case.
    Kobayashi M, Okamoto K, Nakatani H, Okabayashi T, Namikawa T, Ichikawa K, Kitagawa H, Araki K.
    Surg Today; 2006 Aug 11; 36(8):727-32. PubMed ID: 16865518
    [Abstract] [Full Text] [Related]

  • 6. Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report.
    Escobar GA, Robinson WA, Nydam TL, Heiple DC, Weiss GJ, Buckley L, Gonzalez R, McCarter MD.
    BMC Cancer; 2007 Jan 17; 7():13. PubMed ID: 17229322
    [Abstract] [Full Text] [Related]

  • 7. Successful resection of an advanced duodenal gastrointestinal stromal tumor after down-staging with imatinib: report of a case.
    Ludvigsen L, Toxvaerd A, Mahdi B, Krarup-Hansen A, Bergenfeldt M.
    Surg Today; 2007 Jan 17; 37(12):1105-9. PubMed ID: 18030576
    [Abstract] [Full Text] [Related]

  • 8. Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy.
    Melichar B, Voboril Z, Nozicka J, Ryska A, Urminská H, Vanecek T, Michal M.
    Intern Med; 2005 Nov 17; 44(11):1163-8. PubMed ID: 16357454
    [Abstract] [Full Text] [Related]

  • 9. Hypoglycaemia in a 63-year-old female with a large, recurrent, metastatic gastrointestinal stromal tumour (GIST).
    Tan G, Teo M, Choo SP.
    J Gastrointest Cancer; 2011 Dec 17; 42(4):263-5. PubMed ID: 21057892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A case of rectal gastrointestinal stromal tumor (GIST) locally resected after long-term chemotherapy with imatinib mesylate].
    Tonooka T, Takiguchi N, Yamamoto H, Nabeya Y, Ikeda A, Kainuma O, Souda H, Cho A, Muto Y, Yanagibashi H, Takano E, Denda T, Nagata M.
    Gan To Kagaku Ryoho; 2014 Nov 17; 41(12):1849-51. PubMed ID: 25731351
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
    Nishida T, Omori T, Ueshima S.
    Gan To Kagaku Ryoho; 2011 May 17; 38(5):733-7. PubMed ID: 21566432
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
    Miyake M, Takeda Y, Hasuike Y, Kashiwazaki M, Mishima H, Ikenaga M, Mano M, Takada Y, Hirota S, Tsujinaka T.
    Gan To Kagaku Ryoho; 2004 Oct 17; 31(11):1791-4. PubMed ID: 15553717
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recent advances in therapy for gastrointestinal stromal tumors.
    Maki RG.
    Curr Oncol Rep; 2007 May 17; 9(3):165-9. PubMed ID: 17430686
    [Abstract] [Full Text] [Related]

  • 19. Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice.
    Agostino NM, Chinchilli VM, Lynch CJ, Koszyk-Szewczyk A, Gingrich R, Sivik J, Drabick JJ.
    J Oncol Pharm Pract; 2011 Sep 17; 17(3):197-202. PubMed ID: 20685771
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.